GlassScriptPhysician profile
Michael Yang Yang
NPI 1265788962
$932.26
in general payments reported to CMS, 2019-2025
12 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.66 · 2021: $30.00 · 2022: $192 · 2023: $95.16 · 2024: $371 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $241.94 | 2023-2025 | Gel-One Cross-Linked Hyaluronate, Activbraid |
| Djo, LLC | $222.30 | 2021-2022 | |
| Depuy Synthes Sales INC. | $102.05 | 2024-2025 | Monovisc, Orthovisc |
| Dynasplint Systems INC. | $70.42 | 2024 | Dynasplint |
| Trice Medical, INC. | $69.12 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $54.10 | 2023-2024 | Exparel, Zilretta, Iovera |
| Abbott Laboratories | $42.38 | 2024 | Lamitrode |
| Ferring Pharmaceuticals INC. | $40.55 | 2025 | Euflexxa |
| Orthofix Medical, INC. | $37.21 | 2024 | Physio-Stim |
| Ultragenyx Pharmaceutical INC. | $29.53 | 2024 | Crysvita |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.59 | 2019 | |
| Intercept Pharmaceuticals, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.